Marker Chromosomes in Korean Patients: Incidence, Identification and Diagnostic Approach

Journal of Korean Medical Science

Volumn 18, Issue 6, 2003, Pages 773-778

  Woo, Hee Yeon ^a   Cho, Hyun Jung ^a   Kong, Sun Young ^a   Kim, Hee Jin ^a   Jeon, Hyun Bae ^a   Kim, Eun Chi ^a   Park, Hyosoon ^a   Kim, Young Jae ^a   Kim, Sun Hee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Chromosome Markers; Fluorescence; Genetic Markers; In situ Hybridization; Incidence

Indexed keywords

ARTICLE; CHROMOSOME 15; CHROMOSOME 22; CHROMOSOME ANALYSIS; CHROMOSOME IDENTIFICATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INCIDENCE; KARYOTYPE; KOREA; MAJOR CLINICAL STUDY; MARKER CHROMOSOME; MOLECULAR PROBE; PATIENT; SUPERNUMERARY CHROMOSOME; TURNER SYNDROME; X CHROMOSOME; Y CHROMOSOME;

EID: 0347064117     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.6.773     Document Type: Article

References (24)

1. Robinson A. Demography and prevalence of Turner syndrome. In: Rosenfeld R, Grumbach M, Eds. Turner Syndrome. New York: Marcel Dekker 1990; 93-9.
2. Buckton KE, Spowart G, Newton MS, Evans HJ. Forty four probands with an additional "marker" chromosome. Hum Genet 1985; 69: 353-70.
3. Warburton D. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am J Hum Genet 1991; 49: 995-1013.
4. Hook EB, Schreinemachers DM, Willey AM, Cross PK. Rates of mutant structural chromosome rearrangements in human fetuses: data from prenatal cytogenetic studies and associations with maternal age and parental mutagen exposure. Am J Hum Genet 1983; 35: 96-109.
5. Callen DF, Eyre H, Yip MY, Freemantle J, Haan EA. Molecular cytogenetic and clinical studies of 42 patients with marker chromosomes. Am J Med Genet 1992; 43: 709-15.
6. Crolla JA, Dennis NR, Jacobs PA. A non-isotopic in situ hybridization study of the chromosomal origin of 15 supernumerary marker chromosomes in man. J Med Genet 1992; 29: 699-703.
7. Mitelman F (ed) ISCN. An international system for human cytogenetic nomenclature. Tennessee: Karger, Basel, 1995.
8. Crolla JA. FISH and molecular studies of autosomal supernumerary marker chromosomes excluding those derived from chromosome 15: II. Review of the literature. Am J Med Genet 1998; 75: 367-81.
9. Blennow E, Nielsen KB, Telenius H, Carter NP, Kristoffersson U, Holmberg E, Gillberg C, Nordenskjold M. Fifty probands with extra structurally abnormal chromosomes characterized by fluorescence in situ hybridization. Am J Med Genet 1995; 55: 85-94.
10. Flejter WL, Bennett-Baker PE, Ghaziuddin M, McDonald M, Sheldon S, Gorski JL. Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation. Am J Med Genet 1996; 61: 182-7.
11. Crolla JA, Harvey JK, Sitch FL, Dennis NR. Supernumerary marker 15 chromosomes: a clinical, molecular and FISH approach to diagnosis and prognosis. Hum Genet 1995; 95: 161-70.
12. Huang B, Crolla JA, Christian SL, Wolf-Ledbetter ME, Macha ME, Papenhausen PN, Ledbetter DH. Refined molecular characterization of the breakpoints in small inv dup(15) chromosomes. Hum Genet 1997; 99: 11-7.
13. Webb T, Hardy CA, King M, Watkiss E, Mitchell C, Cole T. A clinical, cytogenetic and molecular study of ten probands with supernumerary inv dup(15) marker chromosomes. Clin Genet 1998; 53: 34-43.
14. Robinson WP, Binkert F, Giné R, Vazquez C, Müller W, Rosenkranz W, Schinzel A. Clinical and molecular analysis of five inv dup(15) patients. Eur J Hum Genet 1993; 1: 37-50.
15. Crolla JA, Howard P, Mitchell C, Long FL, Dennis NR. A molecular and FISH approach to determining karyotype and phenotype correlations in six patients with supernumerary marker(22) chromosomes. Am J Med Genet 1997; 72: 440-7.
16. Kessel E, Pfeiffer RA. 47,XY,+der(11;22)(q23;q12) following balanced translocation t(11;22)(q23;q12)mat. Remarks on the problem of trisomy 22. Hum Genet 1977; 37: 111-6.
17. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995; 95: 607-29.
18. Madlej R, Lobaccaro JM, Berta P, Belon C, Leheup B, Toublanc JE, Weill J, Chevalier C, Dumas R, Sultan C. Screening for Y-derived sex determining gene SRY in 40 patients with Turner syndrome. J Clin Endocrinol Metab 1992; 75: 1289-92.
19. Page DC. Y chromosome sequences in Turner's syndrome and risk of gonadoblastoma or virilization. Lancet 1994; 343: 240.
20. Macera MJ, Sherman J, Shah HO, Blumberg DL, Buttice LS, Lin JH, Verna RS. Identification of a non-fluorescent isodicentric Y chromosome by molecular cytogenetic techniques. Clin Genet 1994; 46: 364-467.
21. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma molecular definition of the susceptibility region of the Y chromosome. Am J Hum Genet 1995; 57: 1400-7.
22. Kushnick T, Irons TG, Wiley JE, Gettig EA, Rao KW, Bowyer S. 45,X/46,r(X) with syndactyly and severe mental retardation. Am J Med Genet 1987; 28: 567-74.
23. Wolff D, Brown CJ, Schwartz S, Duncan AMV, Surti U, Willard HF. Small marker X chromosomes lack the X inactivation center: implications for karyotype/phenotype correlations. Am J Hum Genet 1995; 55: 87-95.
24. Yorifuji T, Muroi J, Kawai M, Uematsu A, Furusho K, Sasaki H, Momoi T, Kaji M, Yamanaka C, Furusho K. Uniparental and functional X disomy in Turner syndrome patients with unexplained mental retardation and X derived marker chromosomes. J Med Genet 1998; 35: 539-44.